Login to Your Account


Antriabio’s basal insulin dream takes flight

By Michael Fitzhugh
Staff Writer

Monday, April 28, 2014
Seven big trailers owned by Antriabio Inc. sit parked in Boulder, Colo., holding the keys to a dream deferred: Inside is the equipment PR Pharmaceuticals Inc. (PRP) once used to manufacture microparticles for its experimental sustained-release formulation of basal insulin, Insular. Outside are the rough realities that drove it into Chapter 11 bankruptcy in 2008.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription